This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n8http://linked.opendata.cz/resource/drugbank/drug/DB04182/identifier/drugbank/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n11http://linked.opendata.cz/resource/drugbank/drug/DB04182/identifier/pdb/
n4http://linked.opendata.cz/resource/drugbank/property/
n6http://linked.opendata.cz/resource/drugbank/drug/DB04182/identifier/pubchem-compound/
xsdhhttp://www.w3.org/2001/XMLSchema#
n7http://linked.opendata.cz/resource/drugbank/drug/DB04182/identifier/pubchem-substance/

Statements

Subject Item
n2:DB04182
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n10:DB04182 n13:DB04182
dcterms:title
(S)-2-Amino-4-[(2s,3r)-2,3,5-Trihydroxy-4-Oxo-Pentyl]Mercapto-Butyric Acid
adms:identifier
n6:46936914 n7:46508110 n8:DB04182 n11:KRI
n3:IUPAC-Name
n4:271B4227-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B422D-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B422C-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4229-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B422A-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B422B-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4225-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4223-363D-11E5-9242-09173F13E4C5 n4:271B4226-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4224-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4233-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4234-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B422E-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B422F-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4231-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4230-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4232-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4239-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B423B-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B423C-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4238-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4237-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B423A-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4228-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4235-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4236-363D-11E5-9242-09173F13E4C5